Log on / register
Feedback | Support | My details
Open AccessResearch article

The presence of β2-adrenoceptors sensitizes α2A-adrenoceptors to desensitization after chronic epinephrine treatment

Tasneem Bawa-Khalfe1,4 email, Ghazi F Altememi4 email, Chitra D Mandyam2,4 email, Lindsay A Schwarz4 email, Douglas C Eikenburg4 email and Kelly M Standifer3,4 email

1Tasneem Bawa-Khalfe, Research Center for Cardiovascular Diseases, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas-Houston Health Science Center, Houston, TX, USA

2Chitra D. Mandyam, Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, USA

3Kelly M. Standifer, Ph.D., Dept. Pharmaceutical Sciences, 1110 N. Stonewall, Suite 329, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

4Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA

author email corresponding author email

BMC Pharmacology 2007, 7:16doi:10.1186/1471-2210-7-16

Published: 20 December 2007

Abstract

Background

In addition to the regulation of blood pressure, α2- and β-adrenoceptor (AR) subtypes play an important role in the modulation of noradrenergic neurotransmission in the human CNS and PNS. Several studies suggest that the α2-AR responsiveness in cells and tissues after chronic epinephrine (EPI) or norepinephrine (NE) exposure may vary, depending on the β-AR activity present there. Recently, we reported that in BE(2)-C human neuroblastoma cells (endogenously expressing α2A- and β2-AR), chronic EPI treatment (300 nM) produced a dramatic β-adrenoceptor-dependent desensitization of the α2A-AR response. The aim of this study is to determine if stable addition of a β2-AR to a second neuroblastoma cell line (SH-SY5Y), that normally expresses only α2A-ARs that are not sensitive to 300 nM EPI exposure, would suddenly render α2A-ARs in that cell line sensitive to treatment with the same EPI concentration.

Methods

These studies employed RT-PCR, receptor binding and inhibition of cAMP accumulation to confirm α2-AR subtype expression. Stable clones of SH-SY5Y cells transfected to stably express functional β2-ARs (SHβ2AR4) were selected to compare sensitivity of α2-AR to EPI in the presence or absence of β2-ARs.

Results

A series of molecular, biochemical and pharmacological studies indicated that the difference between the cell lines could not be attributed to α2-AR heterogeneity. We now report that after transfection of functional β2-AR into SH-SY5Y cells (SHβ2AR4), chronic treatment with modest levels of EPI desensitizes the α2A-AR. This effect results from a β2-AR dependent down-regulation of native α2A-ARs by EPI accompanied by enhanced translocation of GRK2 and GRK3 to the membrane (required for GRK-mediated phosphorylation of agonist-occupied receptors).

Conclusion

This study further supports the hypothesis that the presence of the β-AR renders the α2A-AR more susceptible to desensitization with physiological levels of EPI.


© 1999-2008 BioMed Central Ltd unless otherwise stated